Safety of a fifth dose of the Lyme disease vaccine
Part of Infections clinical trials.
This study is for people who have already received four doses of the Lyme vaccine (VLA15) in a previous study. It tests whether a fifth dose is safe and helps the body build more protection against Lyme disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have received all four doses of the Lyme vaccine in the earlier study (C4601003).
- You must have a blood sample taken at the last visit of that study (called V7).
- You need to be in good general health, as judged by a doctor.
- You must be willing to follow the study schedule and procedures.
- You cannot be pregnant or breastfeeding.
- You cannot have serious health issues like bleeding disorders, weak immune system, or cancer, and you must not be on certain medications (e.g., steroids, blood thinners).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how your immune system responds to the bacteria that causes Lyme disease. It may help doctors better understand the disease and improve treatment. The trial includes people with a specific form of Lyme called acrodermatitis chronica atrophicans (a skin condition) and healthy volunteers.
This study evaluates and treats people who currently have active Lyme disease, as defined by CDC criteria. It aims to provide expert care and follow-up while studying the disease.
This research study examines why some people continue to have symptoms months after being treated for Lyme disease. Researchers will compare patients with ongoing symptoms to people who recovered well, to better understand what causes lasting problems and how to help.
This study looks at how a person’s immune system responds after exposure to Ixodes (black-legged) tick bites. It aims to better understand the body’s early immune reaction after tick exposure, using blood tests and small skin samples.
This trial is testing a new blood test to help diagnose Lyme disease (borrelia infection) in children. If you are at the emergency room with symptoms that might be Lyme disease and you have a healthy immune system, you might be able to join.
This trial tests whether taVNS (a noninvasive nerve stimulation done through the skin near the ear) can reduce long-lasting symptoms after Lyme disease. It targets people whose symptoms have stayed for months after standard antibiotic treatment.
Hear when a new Lyme Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.